Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001085363 | SCV000659220 | likely benign | Noonan syndrome 8 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587028 | SCV000698732 | benign | not provided | 2017-07-04 | criteria provided, single submitter | clinical testing | Variant summary: The RIT1 c.237+10C>A variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant. 4/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 64/121326 control chromosomes (1 homozygote) from ExAC, predominantly observed in the European (Non-Finnish) subpopulation at a frequency of 0.00093 (62/66676). This frequency is about 74 times the estimated maximal expected allele frequency of a pathogenic RIT1 variant (0.0000125), suggesting this is likely a benign polymorphism found primarily in the populations of European (Non-Finnish) origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories. Taken together, this variant is classified as benign. |
Gene |
RCV000604079 | SCV000729611 | likely benign | not specified | 2017-08-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001085363 | SCV004050483 | benign | Noonan syndrome 8 | 2023-04-11 | criteria provided, single submitter | clinical testing |